RSKD plans sale of 20,000 Class A shares for $97.8K

RSKD has a planned sale notice for restricted or control securities.

Rhea-AI Filing Summary

RSKD has a planned sale notice for restricted or control securities. A holder filed to sell up to 20,000 Class A ordinary shares through Oppenheimer & Co. Inc. on the NYSE, with an aggregate market value of $97,800.00 and an approximate sale date of 11/28/2025. The filing lists total shares of this class outstanding as 112,306,279.

The seller originally acquired 28,695,225 Class A ordinary shares on 06/29/2017 in a private placement from the issuer, paid in cash. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or future operations and, if applicable, that any Rule 10b5-1 trading plan was adopted without such information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the RSKD Form 144 filing disclose about planned share sales?

The notice discloses a plan to sell up to 20,000 Class A ordinary shares of RSKD through Oppenheimer & Co. Inc. on the NYSE, with an aggregate market value of $97,800.00 and an approximate sale date of 11/28/2025.

How many RSKD shares of this class are outstanding according to the notice?

The filing states that there are 112,306,279 Class A ordinary shares outstanding.

When and how were the RSKD shares being sold originally acquired?

The securities were acquired as Class A ordinary shares on 06/29/2017 in a private placement from the issuer, with 28,695,225 shares purchased for cash.

What representations does the seller make in the RSKD Form 144 notice?

By signing, the seller represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, and that this also applied when any Rule 10b5-1 trading plan or instruction was adopted.

Which broker is handling the planned RSKD share sale and on which exchange?

The planned sale is through Oppenheimer & Co. Inc., located at 85 Broad St., New York, NY 10004, and the shares are to be sold on the NYSE.

What type of securities are covered in this RSKD Form 144?

The filing covers Class A ordinary shares of RSKD that were originally acquired in a private placement from the issuer and are now planned for sale under Rule 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/28/2025 - 02:32 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001449802
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RISKIFIED LTD.
SEC File Number	001-40692
Address of Issuer	220 5TH AVENUE 2ND FLOOR NEW YORK NEW YORK 10001
Phone	(203) 300-9264
Name of Person for Whose Account the Securities are To Be Sold	GENESIS PARTNERS IV LP
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	20000	97800.00	112306279	11/28/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A ordinary	06/29/2017	Private Placement	From the issuer			28695225	06/29/2017	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/28/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	GENESIS PARTNERS IV LP
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)